A bill to amend the Federal Food, Drug, and Cosmetic Act to provide for facilitating the importation into the United States of certain drugs that have been approved by the Food and Drug Administration, and for other purposes.
International Prescription Drug Parity Act - Amends the Federal Food, Drug, and Cosmetic Act to replace certain drug reimportation provisions with provisions requiring manufacturers of prescription drugs, or drugs containing insulin, manufactured in a State and domestically approved and then exported, or domestically approved and manufactured in a registered foreign establishment, to maintain specified shipment records, provide required labeling, and make the records available to U.S. importers.
Directs the Secretary of Health and Human Services to establish related criteria to facilitate importation into the United States of such drugs.
Introduced in Senate
Sponsor introductory remarks on measure. (CR S6793-6795)
Read twice and referred to the Committee on HELP.
Sponsor introductory remarks on measure. (CR S132-134)
Sponsor introductory remarks on measure. (CR S9258)
checking server…
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line